Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Ali Cherif Chefchaouni"'
Autor:
null Hamza SIYAR, null Ali CHERIF CHEFCHAOUNI, null Hassane MAMAD, null Souad BENKIRANE, null Azlarab MASRAR
Publikováno v:
Journal of Pharmaceutical Negative Results. :1568-1575
Introduction: chronic myeloid leukemia is one of the major diseases, which cause death worldwide. Tyrosine kinase is responsible for uncontrolled cell growth and block its function. Its inhibition is a promising route to control the out of control gr
Autor:
Yasmine Bendarkawi, Ali Cherif Chefchaouni, Sihame Lkhoyaali, Hafsa Bechar, Yassine Boudina, Youssef Abercha, Mohammed Jaouad Belahcen, Younes Rahali
Publikováno v:
Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.
Introduction Tamoxifen is widely used for the treatment of hormone-responsive breast cancer. In this article, we report a case of a patient who developed hand deformities following long-term administration of tamoxifen. Case report A 57-year-old woma
Autor:
Sara Mejdoub, Yasmina Tadlaoui, Jamal Lamsaouri, Youssef Moutaouakkil, Yassine Atbib, Yassir Bousliman, Ali Cherif Chefchaouni
Publikováno v:
Le Pharmacien Hospitalier et Clinicien. 56:193-200
Resume Introduction L’objectif cette etude etait de mettre en lumiere l’etat des lieux de l’utilisation des anti-TNF (adalimumab et etanercept) chez les patients atteints de rhumatisme inflammatoire chronique dans une unite de la pharmacie de l
Autor:
Yassir Bousliman, Youssef Moutaouakkil, Yasmina Tadlaoui, Ali Cherif Chefchaouni, Jamal Lamsaouri, Badr Adouani
Publikováno v:
Journal of Oncology Pharmacy Practice. 28:822-826
Introduction Drug shortages have been a growing global problem in recent years. Some of them are of vital necessity and importance for the patient, such as those used to treat pathologies in clinical hematology and oncology departments. The objective
Risk assessment of personnel exposure in a central cytotoxic preparation unit using the FMECA method
Autor:
Nihal Bhirich, Ali Cherif Chefchaouni, Safaa El Medkouri, Oumaima Shytry, Mohammed Jaouad Belahcen, Younes Rahali
Publikováno v:
Journal of Oncology Pharmacy Practice. :107815522311536
Introduction Personnel involved in the preparation of cytotoxics are exposed to them and the resulting risks. To protect themselves, many means of protection are currently implemented. Nevertheless, the exposure of these manipulators remains a possib
Autor:
Chaimaa Nouibi, Ali Cherif Chefchaouni, Hafsa Bechar, Mohammed Jaouad Belahcen, Younes Rahali
Publikováno v:
Journal of Oncology Pharmacy Practice. :107815522211508
Introduction Capecitabine is a molecule of choice in the therapeutic arsenal of anticancer drugs used in Morocco for the treatment of breast cancer and colorectal cancer. Its frequent use imposes a follow-up and a post-prescription monitoring of the
Autor:
Ali Cherif Chefchaouni, Yassine Boudina, Meryem Chennaq, Mohammed Jaouad Belahcen, Younes Rahali
Publikováno v:
Journal of Oncology Pharmacy Practice. :107815522211188
Introduction In the last few years, pharmaceutical technology has evolved. In the field of oncology pharmacy, robots for the preparation of anti-cancer drugs have appeared to progressively replace manual preparation. The objective of this study is to
Autor:
El Baraka, Soumaya, Cherif Chefchaouni, Ali, Bourdaime, Aya, Ouedraogo, Jean-Marie, Shytry, Oumaima, Belahcen, Mohammed-Jaouad, Rahali, Younes
Publikováno v:
Journal of Oncology Pharmacy Practice; Oct2024, Vol. 30 Issue 7, p1152-1159, 8p
Autor:
Bennani, Ismail, Cherif Chefchaouni, Ali, Hafidi, Youssef, Moukafih, Badreddine, El Marrakchi, Soufiane, Bandadi, Fatima-Zahra, Rahali, Younes, El Kartouti, Abdeslam
Publikováno v:
Journal of Oncology Pharmacy Practice; Sep2024, Vol. 30 Issue 6, p1078-1083, 6p
Publikováno v:
Cancer Gene Therapy Week; 5/20/2024, p55-55, 1p